Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome

References

• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-643544
   PubMed Web of Science ®Google Scholar
• Rami SK, Maria CY, Mohamed AKD, et al. Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes. Am J Hematol. 2012;87(11):1006–1009. doi:10.1002/ajh.23303
   PubMed Web of Science ®Google Scholar
• Greenberg PL, Tuechler H, Schanz J, et al. international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–2465. doi:10.1182/blood-2012-03-420489
   PubMed Web of Science ®Google Scholar
• Bektas O, Uner A, Eliacik E, et al. Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems. Turk J Haematol. 2016;33(2):119–126. doi:10.4274/tjh.2014.0455
   PubMed Web of Science ®Google Scholar
• Matteo G. Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome. Haematolocia. 2011;96(3):441–449. doi:10.3324/haematol.2010.033506
   PubMed Web of Science ®Google Scholar
• Jacobs NL, Holtan SG, Porrata LF, et al. Host immunity affects survival in myelodysplastic syndromes: independent prognostic value of the absolute lymphocyte count. Am J Hematol. 2010;85(3):160–163. doi:10.1002/ajh.21618
   PubMed Web of Science ®Google Scholar
• Saeed L, Patnaik MM, Begna KH, et al. Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients. Blood Cancer J. 2017;7(3):e550. doi:10.1038/bcj.2017.30
   PubMed Web of Science ®Google Scholar
• Shi C, Gong S, An W, et al. Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes. BMC Cancer. 2022;22(1):127. doi:10.1186/s12885-022-09248-2
   PubMed Web of Science ®Google Scholar
• An W, Gao P, Ningning W, et al. Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes. BMC Cancer. 2021;21(1):546. doi:10.1186/s12885-021-08303-8
   PubMed Web of Science ®Google Scholar
• Sheng L, Luo M, Sun X, et al. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. Int J Cancer. 2013;133(11):2720–2725. doi:10.1002/ijc.28284
   PubMed Web of Science ®Google Scholar
• Qi Q, Geng Y, Sun M, et al. Hyperfibrinogen is associated with the systemic inflammatory response and predicts poor prognosis in advanced pancreatic cancer. Pancreas. 2015;44(6):977–982. doi:10.1097/MPA.0000000000000353
   PubMed Web of Science ®Google Scholar
• Son HJ, Park JW, Chang HJ, et al. Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. Ann Surg Oncol. 2013;20(9):2908–2913. doi:10.1245/s10434-013-2968-8
   PubMed Web of Science ®Google Scholar
• McGowan-Jordan J, Simons A, Schmid M. ISCN 2016: An International System for Human Cytogenomic Nomenclature (2016). S KARGER AG; 2016.
   Google Scholar
• Li MM, Datto M, Duncavage EJ, et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, American society of clinical oncology, and college of American pathologists. J Mol Diagn. 2017;19(1):4–23. doi:10.1016/j.jmoldx.2016.10.002
   PubMed Web of Science ®Google Scholar
• Sahni A, Simpson-Haidaris PJ, Sahni SK, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2(FGF-2). J Thromb Haemost. 2008;6(1):176–183. doi:10.1111/j.1538-7836.2007.02808.x
   PubMed Web of Science ®Google Scholar
• Qiu J, Yanping Y, Yunfeng F, et al. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer. J Obstet Gynaecol Res. 2012;38(4):651–657. doi:10.1111/j.1447-0756.2011.01780.x
   PubMed Web of Science ®Google Scholar
• Steinbrecher KA, Horowitz NA, Blevins EA, et al. Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta (2) engagement of fibrinogen. Cancer Res. 2010;70:2634–2643. doi:10.1158/0008-5472.CAN-09-3465
   PubMed Web of Science ®Google Scholar
• Shu YJ, Weng H, Bao RF, et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer. 2014;14:566. doi:10.1186/1471-2407-14-566
   PubMed Web of Science ®Google Scholar
• Staton CA, Brown NJ, Lewis CE. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther. 2003;3:1105–1120. doi:10.1517/14712598.3.7.1105
   PubMed Web of Science ®Google Scholar
• Witsch E, Sela M, Yarden Y. Roles for growth factors in cancer progression. Physiology. 2010;25:85–101. doi:10.1152/physiol.00045.2009
   PubMed Web of Science ®Google Scholar
• Pichler M, Dalpiaz O, Ehrlich GC, et al. Validation of the Preoperative Plasma Fibrinogen Level as a Prognostic Factor in a European Cohort of Patients with Localized Upper Tract Urothelial Carcinoma. J Urol. 2014;191(4):920–925. doi:10.1016/j.juro.2013.10.073
   PubMed Web of Science ®Google Scholar
• Martin DB, Alexander DH, Katja S, et al. (2017) Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia. Hematol Oncol. 2017;35(4):789–796. doi:10.1002/hon.2307
   PubMed Web of Science ®Google Scholar
• Niu JY, Tian T, Zhu HY, et al. Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma. Ann Hematol. 2018;97:1841–1849. doi:10.1007/s00277-018-3382-x
   PubMed Web of Science ®Google Scholar
• Castelli R, Bergamaschini L, Teatini T, et al. Does outcome/survival of patients with myelodysplastic syndromes should be predicted by reduced levels of ADAMTS – 13? Results from a pilot study. Clin Lymphoma Myeloma Leuk. 2020;20(8):e461–e467. doi:10.1016/j.clml.2019.12.016
   PubMed Web of Science ®Google Scholar
• Ogura S, Yonei S, Tanigawa T, et al. Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes. Ann Hematol. 2020;99(1):189–191. doi:10.1007/s00277-019-03863-z
   PubMed Web of Science ®Google Scholar